Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) EPS (Weighted Average and Diluted) (2022 - 2026)

bioAffinity Technologies has reported EPS (Weighted Average and Diluted) over the past 5 years, most recently at -$0.81 for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 83.12% to -$0.81 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$6.83 through Mar 2026, up 57.6% year-over-year, with the annual reading at -$8.66 for FY2025, 61.51% up from the prior year.
  • EPS (Weighted Average and Diluted) was -$0.81 for Q1 2026 at bioAffinity Technologies, up from -$1.11 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.22 in Q4 2022 and troughed at -$6.28 in Q4 2024.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.26 (2023), against an average of -$1.56.
  • Year-over-year, EPS (Weighted Average and Diluted) crashed 2315.38% in 2024 and then skyrocketed 83.12% in 2026.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.22 in 2022, then tumbled by 218.18% to -$0.26 in 2023, then crashed by 2315.38% to -$6.28 in 2024, then soared by 82.32% to -$1.11 in 2025, then rose by 27.03% to -$0.81 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's EPS (Weighted Average and Diluted) are -$0.81 (Q1 2026), -$1.11 (Q4 2025), and -$4.74 (Q3 2025).